While Asia Pacific has been very successful in drastically reducing the malaria burden, over the past 10 years only three countries in the region successfully earned their malaria-free status: Maldives in 2015, Sri Lanka in 2016, and China in 2021. China's eradication of malaria in particular was a momentous feat, making it a potential blueprint for other countries in the region. Let's examine the lessons we can learn from China's malaria elimination strategy.
Malaria, the oldest disease that has plagued mankind for centuries, continues to wreak havoc globally. The World Health Organisation (WHO's) 2023 World Malaria Report revealed that global malaria cases in 2022 surpassed pre-COVID-19 levels. The Asia Pacific region also continues to be affected by this enduring fever. India accounted for 66 per cent of malaria cases in the WHO South-East Asia Region in 2022, with nine countries in the region contributing to about 2 per cent of the global burden. Notably, Myanmar experienced a seven-fold increase in cases between 2019 and 2022 due to political and social instability, impacting neighbouring countries like Thailand, where cases doubled. Bangladesh and Indonesia also saw increases in malaria cases between 2021 and 2022.
Understanding China's Approach
The WHO certified China as malaria-free in 2021, marking a significant achievement. Malaria had been endemic in China for many years, with an estimated 30 million cases annually and a 1 per cent fatality rate in 1949. The elimination of malaria in this populous nation represents a major milestone not only for Chinese public health but also for global efforts towards malaria eradication.
This story is from the BioSpectrum Asia April 2024 edition of BioSpectrum Asia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the BioSpectrum Asia April 2024 edition of BioSpectrum Asia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Australia invests $1.89B for health and medical research transformation
The government is investing in a once in a generation transformation of health and medical research in Australia.
NZ suggests new way to prevent rheumatic heart disease progression
A new way of delivering treatment to prevent rheumatic heart disease progression is significantly less painful than an almost 70-year-old existing treatment, a University of Otago-led study in New Zealand (NZ) has found.
WHO prequalifies Takeda's dengue vaccine
A new vaccine for dengue has received prequalification from the World Health Organization (WHO).
GIBF invests $10M in Israel's Nectin Therapeutics to advance ADCs
Guangzhou-Israel Biotechnology Fund (GIBF) has invested $10 million in Nectin Therapeutics.
HOYA Group to distribute AIassisted lesion detection device in US
Japan-based HOYA Group Company, PENTAX of America, Inc. (PENTAX Medical, a division of HOYA Group) and MAGENTIQ-EYE, an artificial intelligence (AI)-based medical device company, have announced their intention to form a partnership in the field of AI in gastroenterology and to examine further collaboration and strategic partnerships.
Saudi Arabia pledges $500M to protect children from polio
At the first-ever World Economic Forum (WEF) Special Meeting hosted in Riyadh recently, the Kingdom of Saudi Arabia has pledged $500 million over the next five years to support the work of the Global Polio Eradication Initiative (GPEI).
Scientists explore use of COVID-19 variant vaccine against other coronaviruses
An international consortium of researchers developing a vaccine against troublesome COVID-19 variants will receive additional CEPI funding to investigate whether it could also protect against other deadly coronaviruses.
How Thai Biotech is Thriving with Innovations
Thailand's biotech industry is rapidly evolving, positioning itself as a key player in the ASEAN regions and the global biotechnology landscape. With a strategic focus on research and development, supportive government policies and a burgeoning ecosystem of startups and research institutions, Thailand is emerging as a hotspot for biotech innovation in Southeast Asia.
Why multi-use real estate is in demand for life sciences companies
India's Biocon, Enzene Biosciences, and Meteoric Biopharmacueticals, Japan's Daiichi Sankyo, and Singapore's Hummingbird Bioscience, have all recently sought to lease, acquire, and set up shop in a mixed-use space in the US. And for those companies who wish to enter or expand in the US market, New Jersey is a top choice due to its existing infrastructure, cultural connections, robust talent and location.
"The dialogue surrounding pharmaceutical gowning is experiencing significant transformation in 2024 & beyond"
Finland-based Lindström, a leading global provider of workwear, cleanroom workwear, and mat services, is making significant strides in its expansion efforts, particularly in key markets such as India, China, Vietnam, and Turkey.
